THE DEFINITIVE ARTICLE SEARCH FOR THE GLOBAL PHARMACEUTICALS MARKET Advanced Search
This channel: Article Type  >       
 
Most popular article in Financial results  
Ingredients
The Binding Site: financial results for the six months ended 31st March 2008
 
Company:Binding Site Limited
Date Published:30/06/2008
Articles in
Financial results:
Select to view sub-categories of this category
 
 SubjectContributorDate Published
Genmab announces results for the first nine months of 2008



Genmab A/S29/10/2008
Shire's new product portfolio delivers strong quarterly performance



Shire PLC29/10/2008
Siegfried suffers setback in 3rd quarter



Siegfried Holding AG28/10/2008
GLAXOSMITHKLINE AND AFFIRIS SIGN AN EXCLUSIVE LICENCE AND OPTION AGREEMENT FOR THERAPEUTIC ALZHEIMER'S DISEASE CANDIDATE VACCINES



PR&D - Public Relations for Research and Education24/10/2008
Icon reports 35% increase in revenue and 45% increase in operating income



ICON plc21/10/2008
AFFiRiS - MIG-FONDS INCREASES INVESTMENT BY EURO 3 MILLION



PR&D - Public Relations for Research and Education26/09/2008
Stallergenes: first half year 2008: a 19% increase in operating profit and net profit



Stallergenes27/08/2008
To the Financial Analysts of Siegfried Holding AG and to the Press Agencies



Siegfried Holding AG19/08/2008
Lifecycle Pharma A/S to host conference call announcing interim results for the first half of the year 2008



Lifecycle Pharma A/S18/08/2008
Lifecycle Pharma's updated financial calendar 2008



Lifecycle Pharma A/S14/08/2008
Serentis announces new investment to advance dermatology pipeline



Serentis12/08/2008
Covidien reports third-quarter 2008 results



Covidien Ltd05/08/2008
Sorin Group announces Q2 2008 preliminary results



The Sorin Group25/07/2008
Covidien declares quarterly cash dividend



Covidien Ltd16/07/2008
Stallergenes: Q2 2008 sales up 18% revision upwards of 2008 sales growth



Stallergenes11/07/2008
The Binding Site: financial results for the six months ended 31st March 2008



Binding Site Limited30/06/2008
Nutrilite(TM) passes US$3 billion mark in annual sales



Alticor, Inc.24/06/2008
ICON Plc ('ICON' or the 'COMPANY') proposed bonus share issue to double number of shares in issue



ICON plc17/06/2008
PROXY Governance endorses all four Biogen Idec director nominees



Biogen Idec12/06/2008
Respite care investment needs close scrutiny



Multiple Sclerosis Society10/06/2008
 
   
   
 
© CMP information Ltd 2007
Terms and Conditions  Privacy Policy